Authors
Latest:
Innovation with GenAI: Lessons from Life Sciences and BeyondBy embracing practical, human-centered use cases, life sciences companies are breaking free from GenAI “pilotitis” and demonstrating how scalable AI solutions can help transform patient care and provider efficiency.
Latest:
Streamlining Clinical Trials with Site AugmentationImagine a world where clinical trials move seamlessly from concept to completion, staffing shortages are a thing of the past and patient recruitment happens at a record speed. Join Marken’s patient centric solutions expert and our featured guest for a dynamic discussion on how customizable site augmentation programs are accelerating life-saving treatments to market faster through scalable, flexible decentralized strategies. Learn practical solutions for streamlining on-site, remote or hybrid trials by matching dedicated clinical research professionals to your site’s unique needs, relieving staff burdens and empowering your team to focus on what matters most – patient care.
Latest:
Democratizing AI: Bridging the Intelligence Divide in Commercial Life SciencesSmall and emerging biopharma have been historically reserved about artificial intelligence. But, writes Alan Kalton, AI solutions have matured, been proven, and are no longer a risky investment for small to mid-size companies.
Latest:
Realistic Net-Zero Goals for PharmaHow temperature-controlled containers can play key role in the industry's mission for carbon neutrality across the supply chain.
Latest:
M&A in Pharma: Balancing Growth and RiskWhat factors should be considered—and how can both parties benefit long-term?
Latest:
What Will Change in the Pharma Industry Look Like?Exploring how current and future legislation may impact the role of pharmacy benefit managers (PBMs).
Latest:
What Health & Wellness Companies Need to Know About the New Provider/Patient RelationshipHow has the provider-patient relationship transformed over the past two years, and what care are consumers craving?
Latest:
Pharma's Journey with Patient Family Advisory CouncilsIncluding patient and family feedback in our discussions will help shape our understanding of their perception of provided care and services and how we operate as a whole.
Latest:
Creating Value from Compliance DataHow maximizing the intelligence gained from brand engagement compliance activities can help drive pharmaceutical company commercial decisions.
Latest:
Streamlining for Safety: Navigating Changes and Trends in the Pharmaceutical Supply Chain Post-DSCSAWith its aims to protect healthcare consumers against the dangers of counterfeit, contaminated, stolen or otherwise harmful drugs, the DSCSA represents a significant step forward in securing the pharmaceutical supply chain.
Latest:
Climbing Health Care Costs Result in Elevated Employer VigilanceSoaring healthcare costs show little sign of abating in 2024, and concerns about the affordability of medications and medical services continue to grow, despite investments in technology, clinical innovation, and efforts to manage utilization and waste.
Latest:
Strategic EPCIS Implementation: Optimizing Supply Chain Management through Strategic EPCIS ImplementationThis document outlines key strategies and testing protocols critical for optimizing EPCIS implementation, ensuring that pharmaceutical manufacturers can maintain compliance and operational efficiency.
Latest:
Raising the AlarmHealthcare providers must enhance awareness of counterfeit medicines to protect patients, especially as online drug purchases rise.
Latest:
Pharmaceutical Cold Chain Logistics in the Age of Artificial IntelligenceBuilding strategy, mitigating risk, and achieving success with artificial intelligence.
Latest:
Preparing for the Growth of Cold ChainCardinal Health helps create a more predictable and efficient supply chain by investing in the future of cold-chain storage and transportation.
Latest:
The Promise of RFID for Improving Medication Inventory ManagementRadio frequency identification (RFID) not only helps hospitals boost their medication safety standards, it also allows clinicians to continue to provide quality patient care.
Latest:
The Future State of Oncology: The Rise of Oncology Home CareWhile there are still hurdles to overcome along the way, home healthcare could deliver better patient-centered cancer care, providing improved patient outcomes, enhanced quality of life, and reduced strain on resources.
Latest:
What Do Pharmaceutical Manufacturers Actually Want Most from a Hub?Among a variety of Hub vendors, what specific qualities distinguish differentiated support for drug manufacturers? To help answer this question, CareMetx conducted in-depth interviews and surveys with senior leadership at top manufacturers.
Latest:
New Serialization Mandates Inch CloserPressure is mounting ahead of looming unit-level serialization required by the Drug Supply Chain Security Act—necessitating a wide scope of collaboration on compliance
Latest:
Operating Without a Commercial Blueprint: Empowering the Field for Niche Therapy LaunchesHow emerging biotech companies can create fruitful partnerships between home office commercial teams and the field force to enable this intelligence gathering, while driving commercial success.
Latest:
Evaluating Patient Support Programs: Opportunities and PitfallsAssessing the efficacy of patient support programs is the first step to optimizing their resource allocation and program design for maximized patient benefit.
Latest:
Key Supply Chain Tech Trends for 2023Outlining those advances poised to drive increased use of integrated tactical planning (ITP) in helping manufacturers overcome persistent supply chain obstacles.
Latest:
How the Rise in Self-Injectables Is Impacting Pharmaceutical ManufacturingAs the adoption of biologics rises, demand for home healthcare grows, and conditions like diabetes and autoimmune disorders become more prevalent, self-injectables are here to stay.
Latest:
Technically Speaking: Quality Documentation is One of the Best Ways to Boost PerformanceWhy well-organized documentation is critical at every stage of the process.
Latest:
Delivering Value Beyond the Trial with Real-World EvidenceIn response to the rising importance of real-world evidence (RWE) in showing value to payers beyond traditional clinical trials, key opinion leaders emphasize finding cost-effective approaches, considering diverse patient populations, and using AI to pinpoint which patients will benefit most from treatment.
Latest:
The Impact of Serialization Technology: Ensuring Product Integrity and Regulatory ComplianceThese advancements continue to act as a key driver in helping to boost the security, efficiency, and innovation of global industries, include pharma.
Latest:
Addressing the Threat of Prescription AbandonmentAs the rising cost of prescription medications in the United States becomes an increasing barrier for millions of people, how can we effectively address and improve patient adherence?
